Literature DB >> 18584443

Personality factors associated with psychological distress in testicular cancer survivors.

Vassiliki Siafaka1, Thomas N Hyphantis, Ioannis Alamanos, Georgios Fountzilas, Demosthenis Skarlos, Demetrios Pectasides, Venetsanos Mavreas, Nicholas Pavlidis.   

Abstract

The aim of this study was to investigate symptoms of anxiety and depression in testicular cancer survivors (TCSs) and to identify personality traits associated with psychological distress in these patients by means of the MMPI (Hathaway & McKinley, 1943). A total of 50 TCSs and 50 age-adjusted healthy men participated in the study, and we used the following self-report instruments: Montgomery-Asberg Depression Rating Scale (Montgomery & Asberg, 1979), Hamilton Anxiety Rating Scale (Hamilton, 1959, 1969), Spielberger's State-Trait Anxiety Inventory (Spielberger, 1970, 2005), and the MMPI. TCSs displayed higher rates on all psychopathology scales studied compared to controls, but the majority of the patients' scores were within the "normal range," indicating rather mild psychological distress. TCSs' MMPI profiles showed higher rates on Scales 1, 3, 6, and 9 compared to controls; and within the TCSs sample, symptoms of depression were most closely associated with Scales 3 and 5. Similarly, anxiety symptoms were mainly associated with Scale 3. These findings indicate that TCSs present mild symptoms of psychological distress, mainly anxiety and depressive symptoms, suggesting that careful assessment and consultation in TC patients is essential to help them deal with distress after treatment and to minimize possible risk factors.

Entities:  

Mesh:

Year:  2008        PMID: 18584443     DOI: 10.1080/00223890802107958

Source DB:  PubMed          Journal:  J Pers Assess        ISSN: 0022-3891


  5 in total

1.  Use of Medications for Treating Anxiety or Depression among Testicular Cancer Survivors: A Multi-Institutional Study.

Authors:  Shirin ArdeshirRouhaniFard; Paul C Dinh; Patrick O Monahan; Sophie D Fossa; Robert Huddart; Chunkit Fung; Yiqing Song; Darren R Feldman; Robert J Hamilton; David J Vaughn; Neil E Martin; Christian Kollmannsberger; Lawrence Einhorn; Kurt Kroenke; Lois B Travis
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-04-13       Impact factor: 4.254

2.  Primary Chemotherapy in a 47-Year-Old Patient with Giant Ulcerative and Necrotizing Nonseminomatous Testicular Germ Cell Tumor.

Authors:  Sophia Stock; Julian Marcon; Michael Chaloupka; Armin Becker; Wolfgang G Kunz; Steffen Ormanns; Theresia Pichler; Friederike H A Mumm; Julian W Holch; Lars H Lindner
Journal:  Case Rep Oncol       Date:  2021-04-15

3.  Long-term recovery of normal sexual function in testicular cancer survivors.

Authors:  Paolo Capogrosso; Luca Boeri; Matteo Ferrari; Eugenio Ventimiglia; Giovanni La Croce; Umberto Capitanio; Alberto Briganti; Rocco Damiano; Francesco Montorsi; Andrea Salonia
Journal:  Asian J Androl       Date:  2016 Jan-Feb       Impact factor: 3.285

4.  Psychological distress and health-related quality of life up to 2 years after oesophageal cancer surgery: nationwide population-based study.

Authors:  Y J Liu; A Schandl; S Markar; A Johar; P Lagergren
Journal:  BJS Open       Date:  2021-01-08

Review 5.  Late adverse effects and quality of life in survivors of testicular germ cell tumour.

Authors:  Michal Chovanec; Jakob Lauritsen; Mikkel Bandak; Christoph Oing; Gry Gundgaard Kier; Michael Kreiberg; Josephine Rosenvilde; Thomas Wagner; Carsten Bokemeyer; Gedske Daugaard
Journal:  Nat Rev Urol       Date:  2021-03-08       Impact factor: 14.432

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.